Special KOL Discussion: Strengthening World Korean Medical Journal (WKMJ)
June 21, 2017
12:00 PM - 2:00 PM
Council Room (18F), The Yale Club
12:00-12:10 PM Opening Statement
DoHyun Cho, PhD
12:10-12:20 PM Introduction of Participants
12:20 PM Buffet Lunch Begins
12:30-12:50 PM The Past for the Future: Introduction to Past Editions and Major Milestones
12:50-1:50 PM Discussions and Proposals
1:50-2:00 PM Closing Remarks
Chul S. Hyun, MD, PhD
DoHyun Cho, PhD
CEO and President, W Medical Strategy Group | Chairman, New York Health Forum
With over a decade’s worth of experience as the former Director General of KHIDI’s USA operation in New York (a Korean government agency), DoHyun Cho now serves as the CEO and President of W Medical Strategy Group, an organization that provides far-sighted analysis, in-depth research and rapid real-time advice for companies in the life sciences industry.
Reporter, BioPharm Insight
Alaric DeArment covers stories on cancer drug development for the life science database and news company, BioPharm Insight. DeArment previously served as an associate editor of Drug Store News from 2008 to 2014, covering the development, distribution, and retail processes for branded and generic drugs.
Chul S. Hyun, MD, PhD
Founder and Former President, World Korean Medical Organization
Chul S. Hyun is the Founder and Former President of World Korean Medical Organization (WKMO), a global network of 140,000 physicians of Korean descent devoted to promoting educational experience and networking among the physicians throughout the world. He is also the Director General of CVH (Center for Viral Hepatitis).
President and CEO, CPR
Joseph Carabello, president and CEO of CPR, is a leader in the developmental and operational machinery of marketing and marketing communications. His efforts are focused on developing key relationships with industry leaders and managing operations.
Joseph P. McMenamin, MD, JD, FCLM
Executive Vice President and Chief Legal Officer, W Medical Strategy Group
Joseph P. McMenamin is an Executive VP and Chief Legal Officer with W Medical Strategy Group. He has more than 20 years' experience in defending pharmaceutical, medical device, and biotech companies in state and federal court. He also advises clients on managing risks related to telemedicine, corporate use of the internet, social media, communications between life science companies and physicians, compliance with FDA regulations.
Senior Director, FTI Consulting
Kimberly Ha is the current Senior Director at FTI Consulting and specializes in Capital Markets and Healthcare. She was previously Global Editor for BioPharm Insight, an independent business intelligence product launched by the Financial Times Group. She has also been a panelist and moderator at major healthcare conferences and events.
Kun Chul Kim
U.S. Correspondent Reporter, The Asia Business Daily
Kun Chul Kim is the U.S. Correspondent Reporter of The Asia Business Daily which is a Korea-based company mainly engaged in publishing business news. The Company provides business news, securities, and economic related digital contents and commercial advertisements through network channels.
Founder and Principal, CPR
Laura Carabello, co-founder and principal of CPR, has been recognized as an entrepreneur and strategy consultant in both domestic and international businesses related to health care and technology. Her expertise stems from decades of business-to-business and direct-to-consumer healthcare and technology.
Executive Director of Business Development, W Medical Strategy Group
Sangji Lee is an Executive Director of Business Development at W Medical Strategy Group. Prior to joining WMSG, she was a researcher at Korea Health Industry Development Institute USA, representing Ministry of Health of Korea.
Intern, W Medical Strategy Group
Shannon Kim is an intern at W Medical Strategy Group. She is currently studying at New York University and majors in Nutrition and Dietetics.
Tae-Wan Kim, PhD
Professor of Pathology and Cell Biology, Columbia University Medical School
Tae-Wan Kim serves as an Assistant Professor of Pathology and Cell Biology at the Columbia University. He focuses his researches on understanding the molecular basis of Alzheimer’s disease using a multidisciplinary approach based on molecular, cellular and chemical biology. He also serves as a Member of Scientific Advisory Board of Smart Biosciences, Inc.
Yeereum Chung, RN
Research Specialist, W Medical Strategy Group
Yeereum Chung is the research specialist at W Medical Strategy Group. She is also a secretariat staff of WKMJ editorial and agenda coordinator of New York Health Forum.
Manager of Business Operations, W Medical Strategy Group
Karen Yook is the Manager of Business Operations at W Medical Strategy Group. She also is an editorial staff of WKMJ and organizing executive of New York Health Forum.